Home > Insider Trading > Filing (0001209191-19-051083)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358762	Reata Pharmaceuticals Inc	RETA	Pharmaceutical Preparations (2834)	113651945

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1662411	Warren James Huff	2801 Gateway Drive Suite 150 Irving TX 75063	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2019-09-23	12,500	$0.00	164,157	No	5	G	Direct
Class A Common Stock	Acquisiton	2019-09-23	12,500	$0.00	12,500	No	5	G	Indirect	By spouse
Class A Common Stock	Disposition	2019-09-23	7,000	$0.00	157,157	No	5	G	Direct
Class A Common Stock	Disposition	2019-09-27	63,000	$86.61	94,157	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	By spouse
No	5	G	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	3,166	Indirect	By Huff 2010 Descendants' Trust

Footnotes

This transaction, undertaken as part of the reporting person's estate planning, involved the partition of community property so that 12,500 shares of Class A common stock became separate property of the reporting person's spouse. The reporting person disclaims beneficial ownership of the shares held by his spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of his spouse's shares for purposes of Section 16 or for any other purpose. Although this transaction is reported as a gift, the reporting person also claims the exception provided by Rule 16a-13.
This transaction, undertaken as part of the reporting person's estate planning, represents the donative transfer of shares of Class A common stock to trusts for the benefit of immediate family members, which trusts have an independent trustee.
This transaction, undertaken as part of the reporting person's estate planning, represents the private transfer of shares of Class A common stock to trusts for the benefit of immediate family members, which trusts have an independent trustee.